Elevation Oncology ELEV 深 沪
等待开盘 04-02 09:30:00 美东时间
0.365
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.365
- 总市值 2161.67万
- 52周最高 2.2599
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.221
- 委 比 0.00%
- 总股本 5922.37万
- 历史最高 16.22
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.221
- 每 手 1
- 风险率 0.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多跨国药企洞察｜默沙东终止康方2亿美元合作项目，跨国药企如何“优中选优”？
（来源：动脉新医药） 编者按： 全球视野下的跨国药企深度洞察——创新、博弈与中国答卷 在全球医药产业发展的宏大叙事中，跨国药企始终扮演着关键角色——他们...
2025-08-12 08:02
Elevation Oncology Completes Merger with Concentra Biosciences
Elevation Oncology ( ($ELEV) ) has issued an update. Elevation Oncology, Inc. a...
2025-07-23 21:48
BRIEF-Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
July 2 (Reuters) - Elevation Oncology Inc ELEV.O: ELEVATION ONCOLOGY INC -LICENSE AGREEMENT WITH CSPC MEGALITH BIOPHARMACEUTICAL TERMINATED AS OF JUNE 26, 2025 - SEC FILING ELEVATION ONCOLOGY INC - TE...
2025-07-03 04:20
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW, ELEV, CRKN on Behalf of Shareholders
NEW YORK, June 12, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2025-06-13 01:57
美股大行评级 | 潜在涨幅434.95%！VNRX获Jones Trading首予"买入"评级，目标价3美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Metsera(MTSR)"买入"评级，目标价从56美元升至62美元</p> <p>• 摩根大通：维持Avidity Biosciences(RNA)"超配"评级，目标价从57美元升至59美元</
2025-06-11 09:43
This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-06-10 20:39
U.S. RESEARCH ROUNDUP-Crane, Ryder System, Terex
June 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Crane, Ryder System and Terex on Tuesday. HIGHLIGHTS * Crane Co ...
2025-06-10 15:17
William Blair Downgrades Elevation Oncology to Market Perform
William Blair analyst Andy Hsieh downgrades Elevation Oncology (NASDAQ:ELEV) from Outperform to Market Perform.
2025-06-10 03:06
BRIEF-Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
June 9 (Reuters) - Elevation Oncology Inc ELEV.O: ELEVATION ONCOLOGY ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES FOR $0.36 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT ELEVATION O...
2025-06-09 20:43
Elevation Oncology Merges with Concentra Biosciences
An update from Elevation Oncology ( ($ELEV) ) is now available. On June 8, 2025...
2025-06-09 20:29
